Sabrina Ena

Title: Sabrina Ena: Innovator in Stem Cell Research

Introduction

Sabrina Ena is a prominent inventor based in Montigny-le-Tilleul, Belgium. She has made significant contributions to the field of stem cell research, particularly in the differentiation of mesenchymal stem cells (MSC). Her innovative methods have the potential to enhance transplantation properties, making her work vital in regenerative medicine.

Latest Patents

Sabrina Ena holds a patent for "Methods for differentiating mesenchymal stem cells." This application discloses a method for obtaining MSC-derived cells with improved transplantation properties. The method includes a cell size reduction step, characterized by contacting MSC or MSC-derived cells in vitro or ex vivo with heparin or a derivative or analogue thereof at a concentration of at least 0.01 IU/ml. Additionally, the application provides a method for obtaining mesenchymal stem cell-derived cells from MSC, involving the use of FGF-2, TGF-β, and at least 0.01 IU/ml heparin or its derivatives. The invention also encompasses the so-obtained cells and cell populations, along with further products and their uses.

Career Highlights

Sabrina Ena is associated with Bone Therapeutics S.A., a company focused on developing innovative cell therapy products. Her work at Bone Therapeutics has positioned her as a key player in the advancement of stem cell therapies.

Collaborations

Sabrina collaborates with notable colleagues, including Sandra Pietri and Xuan Mai Nguyen. Their combined expertise contributes to the success of their research initiatives.

Conclusion

Sabrina Ena's contributions to stem cell research through her innovative methods and collaborations highlight her importance in the field. Her work continues to pave the way for advancements in regenerative medicine.